NEWS RELEASE 03.28.2026 Arrow

REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS

NEWS RELEASE 03.05.2026 Arrow

AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE

NEWS RELEASE 03.04.2026 Arrow

AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND

NEWS RELEASE 02.24.2026 Arrow

AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

NEWS RELEASE 02.13.2026 Arrow

AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT

NEWS RELEASE 02.12.2026 Arrow

EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS

NEWS RELEASE 02.03.2026 Arrow

AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

NEWS RELEASE 01.28.2026 Arrow

AMGEN ANNOUNCES WEBCAST OF 2025 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

NEWS RELEASE 01.07.2026 Arrow

AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

NEWS RELEASE 01.06.2026 Arrow

AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE

Earnings

Show all
ALL RESULTS 

Data as of:

Minimum 15 minutes delayed. Source: LSEG

MORE STOCK